Heterogeneity impacts biomarker discovery for precision medicine
Kenneth Smith, View ORCID ProfileSharlee Climer
doi: https://doi.org/10.1101/2022.02.14.22270972
Kenneth Smith
1University of Missouri – St. Louis, Missouri, USA
Sharlee Climer
1University of Missouri – St. Louis, Missouri, USA
Article usage
Posted August 01, 2022.
Heterogeneity impacts biomarker discovery for precision medicine
Kenneth Smith, Sharlee Climer
medRxiv 2022.02.14.22270972; doi: https://doi.org/10.1101/2022.02.14.22270972
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2841)
- Dermatology (243)
- Emergency Medicine (428)
- Epidemiology (12551)
- Forensic Medicine (10)
- Gastroenterology (803)
- Genetic and Genomic Medicine (4425)
- Geriatric Medicine (401)
- Health Economics (715)
- Health Informatics (2849)
- Health Policy (1047)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4184)
- Nursing (222)
- Nutrition (617)
- Oncology (2200)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (267)
- Palliative Medicine (81)
- Pathology (486)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6775)
- Radiology and Imaging (1487)
- Respiratory Medicine (899)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (174)